These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24332646)

  • 1. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
    Pond GR; Di Lorenzo G; Necchi A; Eigl BJ; Kolinsky MP; Chacko RT; Dorff TB; Harshman LC; Milowsky MI; Lee RJ; Galsky MD; Federico P; Bolger G; DeShazo M; Mehta A; Goyal J; Sonpavde G
    Urol Oncol; 2014 May; 32(4):501-8. PubMed ID: 24332646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma.
    Pond GR; Milowsky MI; Kolinsky MP; Eigl BJ; Necchi A; Harshman LC; Di Lorenzo G; Dorff TB; Lee RJ; Sonpavde G
    Clin Genitourin Cancer; 2014 Dec; 12(6):440-6. PubMed ID: 24787971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
    Necchi A; Eigl BJ; Yang ES; Bae S; Chandrashekar D; Chen D; Naik G; Mehta A; Giannatempo P; Colecchia M; Gordetsky J; Wei S; Cooper T; Varambally S; Sonpavde G
    Eur Urol Focus; 2018 Sep; 4(5):733-736. PubMed ID: 28753783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
    Mollica V; Massari F; Maruzzo M; Bimbatti D; Claps M; Maiorano BA; Vitale MG; Iacovelli R; Ermacora P; Roviello G; Calabrò F; Caffo O; Vignani F; Grillone F; Pierantoni F; Di Napoli M; Mennitto A; Marchetti A; Mattana A; Cavo A; Bassanelli M; Formisano L; Prati V; Giudice GC; Buti S
    Clin Genitourin Cancer; 2024 Jun; 22(3):102074. PubMed ID: 38616147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.
    Buonerba C; Di Lorenzo G; Pond G; Cartenì G; Scagliarini S; Rozzi A; Quevedo FJ; Dorff T; Nappi L; Lanzetta G; Pagliaro L; Eigl BJ; Naik G; Ferro M; Galdiero M; De Placido S; Sonpavde G
    Front Pharmacol; 2016; 7():487. PubMed ID: 28066240
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
    Xu J; Li G; Zhu SM; Cai QL; Wang Z; Yang X; Zhang HT; Niu YJ
    BMC Cancer; 2019 Jun; 19(1):625. PubMed ID: 31238987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.
    Zhang S; Zhu Y; Ye D
    Oncotarget; 2015 Oct; 6(31):32212-9. PubMed ID: 26311739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study.
    Necchi A; Lo Vullo S; Perrone F; Raggi D; Giannatempo P; Calareso G; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Togliardi E; Colecchia M; Busico A; Gloghini A; Testi A; Mariani L; Salvioni R
    BJU Int; 2018 Mar; 121(3):348-356. PubMed ID: 28921872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.
    Wei L; Li Z; Guo S; Ma H; Shi Y; An X; Huang K; Xiong L; Xue T; Zhang Z; Yao K; Luo J; Han H
    Cancer; 2024 May; 130(9):1650-1662. PubMed ID: 38157276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.
    Kim ST; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Oncology; 2010; 79(5-6):363-9. PubMed ID: 21430405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
    Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
    Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy.
    Necchi A; Lo Vullo S; Nicolai N; Raggi D; Giannatempo P; Colecchia M; Catanzaro M; Torelli T; Piva L; Biasoni D; Stagni S; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2016 Dec; 14(6):518-523. PubMed ID: 27050716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
    Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S
    BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed.
    Necchi A; Giannatempo P; Lo Vullo S; Raggi D; Nicolai N; Colecchia M; Perrone F; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2016 Jun; 14(3):231-6. PubMed ID: 26362073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
    Yang MH; Chen TH; Wang HM; Hsieh JC; Huang HC; Hsieh MC; Yen CJ; Wu SY; Hua CH; Lien MY; Chang YF; Wang HC; Chien CY; Huang TL; Lu HJ; Lin JC; Wang CC; Liu YC; Chen JP; Lu WC; Yiu CY; Lin CL; Lou PJ; Chu PY
    BMC Cancer; 2024 Oct; 24(1):1227. PubMed ID: 39369189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute.
    Ornellas AA; Nóbrega BL; Wei Kin Chin E; Wisnescky A; da Silva PC; de Santos Schwindt AB
    J Urol; 2008 Oct; 180(4):1354-9. PubMed ID: 18707720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study.
    Sharma P; Djajadiningrat R; Zargar-Shoshtari K; Catanzaro M; Zhu Y; Nicolai N; Horenblas S; Spiess PE
    Urol Oncol; 2015 Nov; 33(11):496.e17-23. PubMed ID: 26072110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.
    Pagliaro LC; Williams DL; Daliani D; Williams MB; Osai W; Kincaid M; Wen S; Thall PF; Pettaway CA
    J Clin Oncol; 2010 Aug; 28(24):3851-7. PubMed ID: 20625118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
    Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
    Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.